Abstract
The aim of the present study was to describe a method combining easy implementation in a clinical setting with accuracy and precision in quantification of 123I-labeled N-(3-iodoprop-(2E)-enyl)-2beta-carboxymethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to brain dopamine transporter.
Original language | English |
---|---|
Journal | Journal of Nuclear Medicine |
Volume | 46 |
Issue number | 7 |
Pages (from-to) | 1119-27 |
Number of pages | 9 |
ISSN | 0161-5505 |
Publication status | Published - 1 Jul 2005 |